Skip Navigation



NDT Advance Access published online on March 29, 2007

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm113
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/7/1873    most recent
gfm113v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Efrati, S.
Right arrow Articles by Golik, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Efrati, S.
Right arrow Articles by Golik, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

N-acetylcysteine attenuates NSAID-induced rat renal failure by restoring intrarenal prostaglandin synthesis

Shai Efrati1,2, Sylvia Berman1,2, Yariv Siman-Tov2, Raffie Lotan2, Zhan Averbukh1, Joshua Weissgarten1 and Ahuva Golik3

1Nephrology Division, 2Research & Development Unit and 3Department of Internal Medicine A, Assaf Harofeh Medical Center, Zerifin 70300, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Israel

Correspondence and offprint requests to: S. Efrati, MD, Head of the Research & Development Unit, Assaf Harofeh Medical Center, Zerifin 70300, Israel. Email: efratishai{at}013.net



  Abstract

Background. Renal failure is a threatening side-effect of NSAID administration, consequent to NSAID-mediated abrogation of prostaglandin synthesis and resultant renal ischaemia. N-acetylcysteine (NAC) has renoprotective properties. We examined effects of NAC in a rat model of NSAID-induced renal failure. Methods. Renal failure was generated in 80 rats by 6-day water deprivation and 3-day 15 mg/kg/day diclofenac injection. The rats were concomitantly treated, or not, by NAC, 40 mg/kg/day. Renal function was evaluated by cystatin C, creatinine and urea. Intrarenal blood flow was measured by laser Doppler. The kidneys were subjected to pathological examination or evaluation of intrarenal NO, H2O2 and PGE2. Results. NAC significantly attenuated deterioration of renal function in diclofenac-treated rats: cystatin C dropped from 2.8 ± 0.35 to 2.2 ± 0.67 mg/l, P = 0.016; creatinine from 1.2 ± 0.97 to 0.96 ± 0.19 mg/dl, P = 0.02; urea from 208.4 ± 57.9 to 157.6 ± 33.7 mg/dl, P = 0.028. Diclofenac-inflicted hystopathological damage was significantly reduced following NAC treatment. Intrarenal medullar blood flow dropped by 51 ± 12.4% in diclofenac-treated rats, but only by 14 ± 3.39% in those receiving NAC after diclofenac injection (P < 0.001). H2O2 was elevated in renal tissues of diclofenac-receiving rats, while decreased in NAC-treated animals. PGE2 release by diclofenac-treated rats dropped significantly, but was restored after NAC administration both in renal cortices (144.7 ± 10.4 vs 19.7 ± 1.5 pmol/ml, P < 0.001) and medullae (148.5 ± 7.3 vs 66.6 ± 7.3 pmol/ml, P < 0.001). Conclusions. In this model of renal failure induced by NSAID administration combined with water deprivation, NAC treatment successfully attenuated the deterioration of renal function by inducing renal vasodilatation, decreasing oxidative stress via inhibition of intrarenal ROS content and restoration of intrarenal PGE2 release back to the basal levels.

Keywords: glutathione; ischaemia; nitric oxide; NSAID; oxidative stress; prostaglandins

Received for publication: 27.11.06
Accepted in revised form: 9. 2.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.